Antibodies against cyclic citrullinated peptide don’t decrease after 6 months of infliximab treatment in refractory rheumatoid arthritis

Anti-citrullinated peptide antibodies (ACPA) and the rheumatoid factor (RF) are well-established serological markers for rheumatoid arthritis (RA). ACPA are very useful in the diagnosis of RA, especially at the early stages of the disease when ACPA have a greater diagnostic value than RF. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolarz, Bogdan, Majdan, Maria, Dryglewska, Magdalena, Darmochwal-Kolarz, Dorota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204106/
https://www.ncbi.nlm.nih.gov/pubmed/20473501
http://dx.doi.org/10.1007/s00296-010-1509-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204106/
https://www.ncbi.nlm.nih.gov/pubmed/20473501
http://dx.doi.org/10.1007/s00296-010-1509-z

Ejemplares similares